EAM
CMD

Eukles Asset Management’s Cantel Medical Corporation CMD Stock Holding History

Eukles Asset Management’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,528
Closed -$179K – 171
2019
Q4 		$179K Hold
2,528
– – 0.15% 92
2019
Q3 		$189K Hold
2,528
– – 0.16% 93
2019
Q2 		$204K Buy
2,528
+53
+2% +$3.73K 0.18% 89
2019
Q1 		$166K Buy
+2,475
New +$187K 0.15% 91

Other funds holding CMD

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return

Eukles Asset Management's CMD Position: Q1 2020 in Review

Eukles Asset Management sold out of Cantel Medical Corporation (CMD) in Q1 2020, closing a stake of 2,528 shares — an estimated $179K sold.

Eukles Asset Management first reported a position in CMD in Q1 2019 and held it in 4 quarters. The position peaked at $204K in Q2 2019. 213 funds tracked by Wall St. Rank hold CMD as of Q1 2020.

  • Eukles Asset Management reported no remaining Cantel Medical Corporation position as of Q1 2020 after selling out during the quarter.
  • Eukles Asset Management sold 2,528 Cantel Medical Corporation shares in Q1 2020, an estimated $179K.
  • Eukles Asset Management first reported a position in Cantel Medical Corporation in Q1 2019 and held it in 4 quarters.
  • Eukles Asset Management's Cantel Medical Corporation position peaked at $204K in Q2 2019.
  • 213 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2020.

Based on Eukles Asset Management's 13F filing for Q1 2020, filed 22 Apr 2020.